EPAS1 and metabolic dysfunction-associated steatotic liver disease: More recently, HRG has been shown to be expressed by hepatocytes as a hypoxia-inducible factor (HIF)2α-dependent mediator, with HIF2α activation contributing to murine and human MASLD progression through HRG upregulation in hepatocytes (36).